FCA Issues Guidance on New U.K. Cryptoasset Regime
The Financial Conduct Authority (FCA), the U.K. financial regulator, clarified how new legislation will apply to different types of cryptoasset activities and when firms will need authorization from the regulator.
The FCA published guidance to help crypto firms prepare for the industry’s new regulatory regime. The document is intended to help market participants determine their regulatory status in advance and prepare for the U.K. authorization process.
The guidance covers the following cryptoasset activities:
- safeguarding cryptoassets;
- providing staking services;
- operating digital asset trading platforms;
- issuing stablecoins that meet regulatory requirements;
- dealing in cryptoassets and arranging cryptoasset transactions.
The new U.K. crypto regulatory regime will take effect on October 25, 2027. However, the FCA will begin accepting authorization applications on September 30, 2026.
The guidance marked another step in preparing the U.K. crypto market for the transition to a comprehensive regulatory framework. In June 2026, the FCA finalized the core rules and accompanying guidance for the new regulatory regime.
The U.K. government also introduced several targeted legislative changes, including limited exemptions from the general requirements and additional clarification for certain technical service providers. The FCA said these changes won’t affect most crypto firms, so market participants can already use the published guidance to prepare their authorization applications.
The FCA will continue refining the guidance. In October 2026, the regulator plans to consult on targeted updates to reflect the latest legislative changes. It also offers pre-application discussions with firms and holds dedicated webinars to help businesses prepare.
In June 2025, tGBP, the first British pound-backed stablecoin, launched in the FCA regulatory sandbox. By December, the regulator had identified developing and finalizing rules for stablecoins denominated in the national currency as a key priority for 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
siRNA rising star ADARx (ADRX.US) launches $350 millions IPO, AbbVie subscribes to 4.9% of shares with a maximum investment of $100 millions
ADARx plans to raise $350 millions and list on Nasdaq. AbbVie will invest up to $100 millions to acquire a 4.9% stake, with a median valuation of $1.8 billions.
Roche (RHHBY.US) weight loss injection shows positive mid-term trial results: average weight loss of 15.5% over 48 weeks, blood sugar levels drop by 2.65%.
The experimental weight-loss injection enicepatide simultaneously lowered blood sugar and body weight in overweight or obese patients with type 2 diabetes during a mid-stage clinical trial.
SPAC company Silicon Valley Acquisition II (SVATU.US) applies for US stock IPO, aiming to raise up to 220 millions USD.
The blank-check company (SPAC) Silicon Valley Acquisition II submitted a filing to the U.S. Securities and Exchange Commission (SEC) on Monday, planning to raise up to 220 millions USD through an initial public offering (IPO).
China’s gold imports exceeded 1,000 tons by August, surpassing the total for all of 2025.

